Bridge City Capital LLC grew its stake in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 7.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 53,286 shares of the business services provider’s stock after acquiring an additional 3,739 shares during the quarter. Exponent comprises approximately 1.3% of Bridge City Capital LLC’s investment portfolio, making the stock its 27th largest holding. Bridge City Capital LLC owned about 0.10% of Exponent worth $4,748,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Private Trust Co. NA increased its stake in Exponent by 129.8% during the 4th quarter. Private Trust Co. NA now owns 278 shares of the business services provider’s stock valued at $25,000 after purchasing an additional 157 shares in the last quarter. Atala Financial Inc acquired a new position in shares of Exponent in the 4th quarter valued at $25,000. Westside Investment Management Inc. purchased a new position in Exponent in the 3rd quarter worth $26,000. Tortoise Investment Management LLC raised its stake in Exponent by 76.7% in the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider’s stock worth $39,000 after acquiring an additional 191 shares during the last quarter. Finally, Trust Co. of Vermont acquired a new stake in Exponent during the 4th quarter worth about $45,000. 92.37% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Exponent news, VP Richard Reiss sold 1,736 shares of the stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now directly owns 1,800 shares of the company’s stock, valued at approximately $154,674. This trade represents a 49.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.10% of the stock is currently owned by corporate insiders.
Exponent Stock Performance
Exponent (NASDAQ:EXPO – Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period in the prior year, the firm posted $0.41 EPS. Sell-side analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More
- Five stocks we like better than Exponent
- How to Profit From Value Investing
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What does consumer price index measure?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Energy and Oil Stocks Explained
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.